Predictors of PASI90 response in patients with psoriasis treated with ınterleukin ınhibitors: observational cohort study
Age of disease onset and being biologically naïve were positively associated with achieving PASI90 response, whereas ustekinumab use was negatively associated. Age of disease onset was the strongest predictor of PASI90. Also, IL23 and IL17 inhibition, especially IL23, appeared to provide a better therapeutic response.
Authors
- Burhan Engіn (ORCID: https://orcid.org/0000-0002-5140-1926)
- Sera Nur Yücesoy (ORCID: https://orcid.org/0000-0001-9170-4262)
- Tümay Ak (ORCID: https://orcid.org/0000-0002-1548-7638)
- Yusuf Demir (ORCID: https://orcid.org/0000-0003-3307-5917)
Institutions
- Istanbul University-Cerrahpaşa (TR)
Publication Details
- Journal
- Anais Brasileiros de Dermatologia
- Published
- 2025-06-18
- DOI
- https://doi.org/10.1016/j.abd.2025.501132
- Citations
- 1
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 0.80